BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, May 3, 2026
Home » Authors » John Brosky

Articles by John Brosky

First patient receives fully implantable heart from French-based Carmat

Dec. 24, 2013
By John Brosky
PARIS – A 75-year old Frenchman was alert and joking with doctors the day after receiving a fully implantable bioprosthetic heart in a 10-hour operation at the Georges Pompidou European Hospital (Paris) on Dec. 18.
Read More

MDD's Orthopedics Extra

Dec. 19, 2013
By John Brosky

The MDD Interview, Part II: Welch Allyn sees proof of performance critical to sales

Dec. 19, 2013
By John Brosky

Mindray moves upmarket with Zonare acquisition

Dec. 16, 2013
By John Brosky

The MDD Interview, Part I: Meyer says Welch Allyn building value from patient experience

Dec. 12, 2013
By John Brosky

RSNA 2013: Fujifilm advances tomosynthesis with next-generation platform

Dec. 5, 2013
By John Brosky
CHICAGO — The Radiological Society of North America (RSNA; Oak Brook, Illinois) opens a window for one week when companies can showcase their newest technologies ahead of actually being able to sell them.
Read More

RSNA 2013 conference: Konica Minolta expands its footprint in primary imaging

Dec. 4, 2013
By John Brosky
CHICAGO — For his first RSNA as President and COO of Konica Minolta Medical Imaging (Wayne, New Jersey), David Widmann unveiled a renewed American arm of the $9 billion Japanese giant that is poised to move vigorously into his targeted segment of Primary Imaging.
Read More

RSNA 2013: Philips gives spectral CT magic touch with detector

Dec. 3, 2013
By John Brosky
CHICAGO — Coming late to spectral imaging for CT, Philips Healthcare (Andover, Massachusetts) believes that magic will win over clinicians.
Read More

The MDD interview Part 2: Drug? Or Device? Next-wave nano products challenge rules

Dec. 2, 2013
By John Brosky

Smartphones, Xbox take control of medical devices

Nov. 26, 2013
By John Brosky
Previous 1 2 … 31 32 33 34 35 36 37 38 39 … 101 102 Next

Popular Stories

  • AI generated image for researcher developing antisense oligonucleotides

    Bio Korea 2026 kicks off with spotlight on oligonucleotides

    BioWorld
    Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
  • Chinabio 2026 partnering

    Chinese biotechs gain leverage as partners in dealmaking

    BioWorld
    China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
  • University of Western Australia patents 5-HT2A/B modulators

    BioWorld Science
    University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
  • Neurons

    AA meeting of minds as PTC, Novartis push votoplam in HD

    BioWorld
    What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
  • Nerves within a melanoma tumor

    Innervation can slow, as well as speed, tumor growth, study finds

    BioWorld
    Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing